New “GPS nanoparticle” delivers a genetic punch to the protein implicated in tumor spread

A newly developed “GPS nanoparticle” injected intravenously can home in on cancer cells to deliver a genetic punch to the protein implicated in tumor growth and spread, according to researchers from Penn State.

Freeline touts positive data for Gaucher disease therapy – Pharmaceutical Technology

Freeline’s gene therapy FLT201 introduces a transgene to produce an engineered GCase variant, the enzyme responsible for the symptoms of Gaucher disease. Credit: dizain via

May 10, 2024

Major surgery complications unaffected by use of renin-angiotensin system inhibitors

There was no difference in major post-operative complications in patients who continued vs. stopped renin-angiotensin system inhibitors (RASIs) before non-cardiac surgery, according to late-breaking research

August 30, 2024

What Do New Breast Cancer Screening Recs Say?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

May 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.